Alzheimer's disease (AD) is driven by amyloid-β (Aβ) plaque accumulation, but the mechanisms behind this process remain unclear. Omega-3 fatty acids, particularly docosahexaenoic acid (DHA), may offer protective effects, though their relationship with Aβ accumulation is not fully understood.
Objective
This study investigated whether serum DHA and eicosapentaenoic acid (EPA) levels, measured 6–9 years before imaging, were inversely associated with cerebral Aβ deposition in cognitively normal older adults in Japan, a population known for high omega-3 intake. We focused on individuals identified as Aβ-positive based on positron emission tomography (PET) scans, as they are at higher risk for AD progression, to assess DHA's potential in mitigating early amyloid pathology.
Methods
An analytical sample of 97 older adults (75–89 years) from the Suita Study was analyzed. Serum DHA and EPA levels were assessed between 2008 and 2012, and amyloid PET was performed between 2016 and 2019. Multiple regression analyses were conducted, adjusting for age, sex, APOE4 status, and cardiometabolic disease.
Results
Among 97 participants (49% males, 8.2% APOE4 carriers), 37.1% (n = 36) had cardiometabolic disease, and 29.8% (n = 29) were Aβ positive. In Aβ-positive individuals, higher serum DHA levels were significantly associated with lower Aβ deposition independent of age, sex and APOE4 status (standardized β = -0.423, p = 0.030). This became non-significant after additionally adjusting for cardiometabolic disease (β = -0.382, p = 0.059). No significant association was found between EPA and Aβ deposition.
Conclusions
Higher long-term DHA levels may help reduce Aβ accumulation in those at risk for AD, supporting its potential role in early prevention.
2024 Alzheimer's disease facts and figures. Alzheimers Dement2024; 20: 3708–3821.
2.
LivingstonGHuntleyJLiuKY, et al.Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet2024; 404: 572–628.
3.
GrantWBBlakeSM. Diet's role in modifying risk of Alzheimer's disease: history and present understanding. J Alzheimers Dis2023; 96: 1353–1382.
4.
GodosJMicekACurrentiW, et al.Fish consumption, cognitive impairment and dementia: an updated dose-response meta-analysis of observational studies. Aging Clin Exp Res2024; 36: 171.
5.
AndriambeloBStiffelMRokeK, et al.New perspectives on randomized controlled trials with omega-3 fatty acid supplements and cognition: a scoping review. Ageing Res Rev2023; 85: 101835.
6.
WoodAHRChappellHFZulyniakMA. Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer's disease. Eur J Nutr2022; 61: 589–604.
7.
KostiRIKasdagliMIKyrozisA, et al.Fish intake, n-3 fatty acid body status, and risk of cognitive decline: a systematic review and a dose-response meta-analysis of observational and experimental studies. Nutr Rev2022; 80: 1445–1458.
8.
Heras-SandovalDPedraza-ChaverriJPérez-RojasJM. Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease. J Neuroinflammation2016; 13: 61.
9.
GrimmMOMettJStahlmannCP, et al.Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-beta by affecting insulin-degrading enzyme. Biochem Cell Biol2016; 94: 534–542.
10.
RenHLuoCFengY, et al.Omega-3 polyunsaturated fatty acids promote amyloid-beta clearance from the brain through mediating the function of the glymphatic system. FASEB J2017; 31: 282–293.
11.
SchuchardtJPCerratoMCeseriM, et al.Red blood cell fatty acid patterns from 7 countries: focus on the Omega-3 index. Prostaglandins Leukot Essent Fatty Acids2022; 179: 102418.
12.
JansenWJOssenkoppeleRKnolDL, et al.Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA2015; 313: 1924–1938.
RoeCMAncesBMHeadD, et al.Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers. Brain2018; 141: 3233–3248.
15.
Rainey-SmithSRGuYGardenerSL, et al.Mediterranean Diet adherence and rate of cerebral Abeta-amyloid accumulation: data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Transl Psychiatry2018; 8: 238.
16.
VillainNChetelatGGrassiotB, et al.Regional dynamics of amyloid-beta deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. Brain2012; 135: 2126–2139.
17.
SekikawaAHigashiyamaALoprestiBJ, et al.Associations of equol-producing status with white matter lesion and amyloid-β deposition in cognitively normal elderly Japanese. Alzheimers Dement (N Y)2020; 6: e12089.
18.
KokuboYKamideKOkamuraT, et al.Impact of high-normal blood pressure on the risk of cardiovascular disease in a Japanese urban cohort: the Suita Study. Hypertension2008; 52: 652–659.
19.
WuMRosanoCButtersM, et al.A fully automated method for quantifying and localizing white matter hyperintensities on MR images. Psychiatry Res2006; 148: 133–142.
20.
KlunkWEEnglerHNordbergA, et al.Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol2004; 55: 306–319.
21.
FischlBSalatDHBusaE, et al.Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron2002; 33: 341–355.
22.
LoprestiBJKlunkWEMathisCA, et al.Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J Nucl Med2005; 46: 1959–1972.
23.
CohenADMowreyWWeissfeldLA, et al.Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches. Neuroimage2013; 71: 207–215.
24.
AndoEMorisakiNAsakuraK, et al.Association between dietary intake and serum biomarkers of long-chain PUFA in Japanese preschool children. Public Health Nutr2020; 24: 1–11.
25.
FowlerCRainey-SmithSRBirdS, et al.Fifteen years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: progress and observations from 2,359 older adults spanning the spectrum from cognitive normality to Alzheimer's disease. J Alzheimers Dis Rep2021; 5: 443–468.
26.
RouchLVirecoulon GiudiciKCantetC, et al.Associations of erythrocyte omega-3 fatty acids with cognition, brain imaging and biomarkers in the Alzheimer's Disease Neuroimaging Initiative: cross-sectional and longitudinal retrospective analyses. Am J Clin Nutr2022; 116: 1492–1506.
27.
UmesawaMYamagishiKIsoH. Intake of fish and long-chain n-3 polyunsaturated fatty acids and risk of diseases in a Japanese population: a narrative review. Eur J Clin Nutr2021; 75: 902–920.
28.
YassineHNArellanesICMazmanianA, et al.Baseline findings of PreventE4: a double-blind placebo controlled clinical trial testing high dose DHA in APOE4 carriers before the onset of dementia. J Prev Alzheimers Dis2023; 10: 810–820.
29.
SekikawaACurbJDUeshimaH, et al.Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J Am Coll Cardiol2008; 52: 417–424.
30.
BilgelMAnYZhouY, et al.Individual estimates of age at detectable amyloid onset for risk factor assessment. Alzheimers Dement2016; 12: 373–379.
31.
PifferiFLaurentBPlourdeM. Lipid transport and metabolism at the blood-brain interface: implications in health and disease. Front Physiol2021; 12: 645646.
32.
NguyenLNMaDShuiG, et al.Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature2014; 509: 503–506.
33.
ChenCTBazinetRP. beta-oxidation and rapid metabolism, but not uptake regulate brain eicosapentaenoic acid levels. Prostaglandins Leukot Essent Fatty Acids2015; 92: 33–40.
34.
LimGPCalonFMoriharaT, et al.A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci2005; 25: 3032–3040.
35.
BazinetRPLayeS. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci2014; 15: 771–785.
36.
PacholkoAIadecolaC. Hypertension, neurodegeneration, and cognitive decline. Hypertension2024; 81: 991–1007.
37.
ZuoWWuJ. The interaction and pathogenesis between cognitive impairment and common cardiovascular diseases in the elderly. Ther Adv Chronic Dis2022; 13: 20406223211063020.
38.
BaeJHLimHLimS. The potential cardiometabolic effects of long-chain ω-3 polyunsaturated fatty acids: recent updates and controversies. Adv Nutr2023; 14: 612–628.
39.
StamlerJElliottPDennisB, et al.INTERMAP: background, aims, design, methods, and descriptive statistics (nondietary). J Hum Hypertension2003; 17: 591–608.
40.
StamlerJElliottPChanQ, et al.INTERMAP appendix tables, tables of contents (tables A). J Hum Hypertension2003; 17: 665–758.
41.
TaniSAtsumiWImatakeK, et al.Associations of higher fish consumption and lifestyle with lower monocyte/HDL-C ratio in a Japanese population: implication for the anti-atherosclerotic effect of fish consumption. J Cardiol2022; 80: 402–409.
42.
TerryALHerrickKAAffulJ, et al.Seafood consumption in the United States, 2013–2016. NCHS Data Brief2018; 321: 1–8.
43.
FeketeMLehoczkiATarantiniS, et al.Improving cognitive function with nutritional supplements in aging: a comprehensive narrative review of clinical studies investigating the effects of vitamins, minerals, antioxidants, and other dietary supplements. Nutrients2023; 15: 5116.
44.
DyallSC. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci2015; 7: 52.
45.
MooreKHughesCFWardM, et al.Diet, nutrition and the ageing brain: current evidence and new directions. Proc Nutr Soc2018; 77: 152–163.
46.
JoffreCReyCLayéS. N-3 polyunsaturated fatty acids and the resolution of neuroinflammation. Front Pharmacol2019; 10: 1022.
47.
CerasuoloMDi MeoIAuriemmaMC, et al.Exploring the dynamic changes of brain lipids, lipid rafts, and lipid droplets in aging and Alzheimer's disease. Biomolecules2024; 14: 1362.
48.
HuXFSandhuSKHarrisWS, et al.Conversion ratios of n-3 fatty acids between plasma and erythrocytes: a systematic review and meta-regression. Br J Nutr2017; 117: 1162–1173.
49.
ClarkeRShipleyMLewingtonS, et al.Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol1999; 150: 341–353.
50.
KobayashiMSasakiSKawabataT, et al.Single measurement of serum phospholipid fatty acid as a biomarker of specific fatty acid intake in middle-aged Japanese men. Eur J Clin Nutr2001; 55: 643–650.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
